scholarly journals Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study

2022 ◽  
Vol 24 (1) ◽  
Author(s):  
Ming Fu ◽  
Hongming Zhou ◽  
Yushi Li ◽  
Hai Jin ◽  
Xiqing Liu
Keyword(s):  
Age Groups ◽  
Hip Osteoarthritis ◽  
Global Burden ◽  
Age Group ◽  
Disability Adjusted Life Years ◽  
Upward Trend ◽  
Medical Institutions ◽  
Disability Adjusted Life ◽  
Life Years ◽  
Disease Study

Abstract Background Hip osteoarthritis is a common disabling condition of the hip joint and is associated with a substantial health burden. We assessed the epidemiological patterns of hip osteoarthritis from 1990 to 2019 by sex, age, and socio-demographic index (SDI). Methods Age-standardized rates (ASRs) were obtained for the incidence and disability-adjusted life years (DALYs) of hip osteoarthritis from 1990 to 2019 for 21 regions, encompassing a total of 204 countries and territories. The estimated annual percentage changes (EAPCs) of ASRs were calculated to evaluate the trends in the incidence and DALYs of hip osteoarthritis over these 30 years. Results Globally, from 1990 to 2019, the age-standardized incidence rate (ASIR) of hip osteoarthritis increased from 17.02 per 100,000 persons to 18.70 per 100,000 persons, with an upward trend in the EAPC of 0.32 (0.29–0.34), whereas the age-standardized DALY rate increased from 11.54 per 100,000 persons to 12.57 per 100,000 persons, with an EAPC of 0.29 (0.27–0.32). In 2019, the EAPCs of the ASIR and age-standardized DALY rate of hip osteoarthritis were positively associated with the SDI of hip osteoarthritis. In 1990 and 2019, the incidence of hip osteoarthritis was unimodally distributed across different age groups, with a peak incidence in the 60–64-year-old age group, whereas the DALYs increased with age. Conclusions The incidence and DALYs of hip osteoarthritis have been increasing globally. The EAPCs of the ASIR and age-standardized DALY rate were particularly significant in developed regions and varied across nations and regions, indicating the urgent need for governments and medical institutions to increase the awareness regarding risk factors, consequences of hip osteoarthritis.

scholarly journals Mapping the Trends in Esophageal Cancer Disease Burden in the United States: Results from the Global Burden of Disease Study 2017

2021 ◽  
Author(s):  
Di Lu ◽  
jianxue Zhai ◽  
Jintao Zhan ◽  
Xiguang Liu ◽  
Xiaoying Dong ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Burden Of Disease ◽  
Disease Burden ◽  
Global Burden ◽  
Disability Adjusted Life Years ◽  
Cancer Disease ◽  
Disability Adjusted Life ◽  
Life Years ◽  
Disease Study ◽  
High Bmi

Abstract Background: Esophageal cancer is the 10th leading cancer in US but given limited research attention. This study aimed to investigate the esophageal cancer disease burden more comprehensively in US. Methods: Having retrieved states-categorized data on esophageal cancer incidence, mortality and disability-adjusted life years from the Global Burden of Disease study online resource, the current trends on esophageal cancer disease burden attributed to different risk factors and their relationship with economic status were analyzed using age-standardized rate and the estimated annual percentage change.Results: In US, the esophageal cancer age-standardized rate of incidence has been stable but age-standardized rates of mortality and disability-adjusted life years trended to decreased with estimated annual percentage changes of -0.237% and -0.471% from 1990 to 2017. Age-standardized rate of incidence was higher in males than in females, but both didn’t increase, so as age-standardized rates of mortality and disability-adjusted life years. The largest increase in age-standardized rates of incidence, mortality and disability-adjusted life years was observed in Oklahoma, whereas the largest decrease was seen in the District of Columbia. Age-standardized rates of mortality and disability-adjusted life years contributed to high BMI or diet low in fruits were growing. per capita disposable personal income trended to negatively correlated with estimated annual percentage changes of incidence, mortality and disability-adjusted life years.Conclusions: The esophageal cancer disease burden in US decreased from 1990 to 2017 but was heavier in males than in females, and increased in economically weaker states and populations with high BMI and low-fruit diet.

scholarly journals Global, regional and national burden of gout, 1990–2017: a systematic analysis of the Global Burden of Disease Study

Rheumatology ◽  
2019 ◽  
Vol 59 (7) ◽  
pp. 1529-1538 ◽  
Author(s):  
Yang Xia ◽  
Qijun Wu ◽  
Hanyuan Wang ◽  
Shuang Zhang ◽  
Yuting Jiang ◽  
...  
Keyword(s):  
Burden Of Disease ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
Disability Adjusted Life Years ◽  
Annual Percent Change ◽  
Percent Change ◽  
Disability Adjusted Life ◽  
Life Years ◽  
Study Results ◽  
Disease Study

Abstract Objectives The burden of gout has been increasing globally. However, little is known about the global, regional and national distribution and time trend of this disease. We present a comprehensive analysis of the Global Burden of Disease Study 2017 on gout burden estimates for 195 countries or territories between 1990 and 2017. Methods Age-standardized prevalence and disability-adjusted life-years of gout were reported between 1990 and 2017 in 195 countries and territories, and associations between these estimates and sociodemographic index (SDI) were further explored. Total and annual percent change between 1990 and 2017 were calculated to quantify the time trends of gout burden. Results Age-standardized prevalence rates (95% uncertainty interval) per 100 000 persons were 790.90 (706.10–881.90) and 253.49 (225.69–284.02) in 2017 in males and females, respectively. The annual percent change in age-standardized prevalence (males, 0.22%; females, 0.38%) and disability-adjusted life-years (males, 0.21%; females, 0.38%) of gout increased every year from 1990 to 2017, globally. The highest increase was detected in high-SDI countries, especially in high-income North America. A non-linear association was observed between burden of gout and SDI, with the lowest estimates of gout burden when SDI value was about 0.6. High BMI was the leading risk factor for the burden of gout. Conclusion These study results suggest a globally rising trajectory of gout burden between 1990 and 2017. More effective interventions, such as detailed and intensive dietary managements and other prevention strategies for reducing obesity, should be carried out to reverse this trend, especially in females and high-SDI countries.

The trend of incidence and burden of neurological disease in Iran between 1990 and 2017: Based on global burden of disease estimations

2019 ◽  
Author(s):  
Hedayat Abbastabar ◽  
Sama Bitarafan ◽  
Mohammad Hossein Harirchian
Keyword(s):  
Burden Of Disease ◽  
Neurological Disease ◽  
Neurological Diseases ◽  
Age Groups ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
Disability Adjusted Life Years ◽  
Disability Adjusted Life ◽  
Life Years ◽  
Increasing Trend

Neurological disease contributes significantly to morbidity and mortality in different ages and geographic areas around the world. The purpose of the current study was to investigate the incidence and disability-adjusted life years (DALYs) trend of neurological disease in Iran during 27 years ago. We used the data of the Global Burden of Disease (GBD) Study to estimate the incidence and DALYs of neurological disease in Iran in different age groups between 1990 and 2017. Age groups were defined in 5 groups including < 5 years, 5-14 years, 15-49 years, 50-69 years, and ≥ 70 years. The incidence number of neurological disease during 1990 to 2017 increased from 7.5 million to more than 12 million and the incidence rate grew as much as 1400 per 100000 populations in Iran. Totally, headache, epilepsy, and Alzheimer were the most common neurological diseases according to incidence and had the most values of DALY in Iran. The highest incidence and DALY of neurological disease was observed in the age group of 15-49 years. This study showed that the incidence and burden of neurological diseases had a dramatic increasing trend during 27 years ago in Iran. Consequently, it is necessary to investigate the causes of the growing trend in future studies. 

Sign in / Sign up

Export Citation Format

Share Document